Return Of Drug Price Hikes Helps CVS’ PBM Smash Revenue Expectations

By John Wilkerson
August 12, 2019 at 3:49 PM
Brand drug makers’ return to price hikes this year helped CVS Health’s pharmacy benefit manager make a lot more money from rebates in the second quarter of this year than Wall Street expected, according to the company’s second quarter earnings report. The Trump administration had planned to ban rebates in Medicare and Medicaid that aren’t shared with consumers at the pharmacy counter, but HHS unexpectedly withdrew that rule this summer . Revenues for the company’s pharmacy benefit manager segment increased...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.